Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.022 AUD | +10.00% | +10.00% | +100.00% |
03-13 | Australian Shares Track Gains of Wall Street Peers as Market Shrugs Off US Inflation Data | MT |
03-13 | LBT Innovations' APAS PharmaQC Completes Primary Validation; Shares Up 79% | MT |
Sales 2022 | 2.13M 1.39M 111M | Sales 2023 | 2.13M 1.4M 112M | Capitalization | 10.37M 6.79M 543M |
---|---|---|---|---|---|
Net income 2022 | -6M -3.93M -314M | Net income 2023 | -22M -14.41M -1.15B | EV / Sales 2022 | 12.4 x |
Net Debt 2022 | 1.5M 982K 78.43M | Net Debt 2023 | 1.37M 895K 71.53M | EV / Sales 2023 | 5.51 x |
P/E ratio 2022 |
-3.58
x | P/E ratio 2023 |
-0.44
x | Employees | 19 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 62.9% |
Latest transcript on LBT Innovations Limited
1 day | +10.00% | ||
1 week | +10.00% | ||
Current month | -8.33% | ||
1 month | -15.38% | ||
3 months | +46.67% | ||
6 months | +340.00% | ||
Current year | +100.00% |
Managers | Title | Age | Since |
---|---|---|---|
Brenton Barnes
CEO | Chief Executive Officer | - | 07/08/16 |
Raymond Ridge
DFI | Director of Finance/CFO | - | 24/08/17 |
Rhys Hill
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel L. Hill
DFI | Director of Finance/CFO | - | 24/08/14 |
Brenton Barnes
CEO | Chief Executive Officer | - | 07/08/16 |
Rebecca Wilson
CHM | Chairman | - | 30/06/23 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 0.022 | +10.00% | 2 118 234 |
26/04/24 | 0.02 | +5.26% | 68,000 |
24/04/24 | 0.019 | -5.00% | 937,939 |
23/04/24 | 0.02 | 0.00% | 1,888,949 |
22/04/24 | 0.02 | 0.00% | 1,515,896 |
Delayed Quote Australian S.E., April 29, 2024 at 01:29 am
More quotes1st Jan change | Capi. | |
---|---|---|
+100.00% | 17.47M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- LBT Stock